feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Thunder beat Timberwolves

trending

Avalanche win tenth straight

trending

Faith Winter dies in crash

trending

Stranger Things Season 5 episodes

trending

Fox leads Spurs victory

trending

Grocery stores Thanksgiving hours

trending

NFL games Week 13 schedule

trending

Hoda Kotb returns to TV

trending

Marlo Thomas remembers Phil Donahue

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Rabies Test Breakthrough: Cheaper, Safer Immunity Check

Rabies Test Breakthrough: Cheaper, Safer Immunity Check

22 Nov

•

Summary

  • New assay detects rabies antibodies safely and affordably.
  • Test confirms immunity levels after vaccination with high accuracy.
  • IAV offers public access to the novel rabies antibody test for ₹500.
Rabies Test Breakthrough: Cheaper, Safer Immunity Check

A groundbreaking, safer, and more affordable assay for detecting rabies antibodies has been developed by the Institute of Advanced Virology (IAV). This novel test accurately confirms immunity levels following vaccination, overcoming the limitations of older, more complex methods that required live virus handling.

The Institute of Advanced Virology's new pseudovirus-based assay offers high throughput and lower costs, making large-scale immune response surveillance feasible, especially in rabies-endemic regions. The test has proven effective for both human and animal rabies vaccination efficacy analysis.

This advancement aims to expand public health accessibility to anti-rabies antibody testing, contributing significantly to global rabies control. For ₹500 per sample, this test is crucial for verifying protective immunity in high-risk groups and ensuring the efficacy of rabies immunisation programs.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
IAV has created a new, safer assay using pseudoviruses to detect rabies neutralizing antibodies in vaccinated individuals and animals.
The new test is simpler, has high throughput, is less costly, and safer to perform than older methods like RFFIT and FAVN.
The Institute of Advanced Virology is offering the new rabies antibody test to the public at ₹500 per sample.

Read more news on

Healthside-arrow

You may also like

Scottish Toddlers' Development Dips During Lockdown

1 day ago • 3 reads

article image

COVID Tech Fights Snakebite Damage

24 Nov • 5 reads

article image

Harvard Study Uncovers 8 Distinct Long Covid Patient Groups

24 Nov • 12 reads

article image

Disease Detection: Nigeria-US Team Wins Big

22 Nov • 268 reads

article image

PGIMER Concludes Stroke Awareness Program

20 Nov • 33 reads

article image